Mansour M, Karmilowicz M, Hawrylik S J, Nalcerio B, Angilly J, Conklyn M J, Lilly C M, Drazen J M, Lee S E, Auperin D D, De Wet J R, Cohan V L, Showell H J, Danley D E
Department of Molecular Sciences, Pfizer Central Research Division, Groton, Connecticut 06340, USA.
Am J Physiol. 1996 Jun;270(6 Pt 1):L1002-7. doi: 10.1152/ajplung.1996.270.6.L1002.
To study the role interleukin (IL)-5 may play in altering airway function in asthma, we have produced recombinant protein for exogenous administration to guinea pigs. The guinea pig IL-5 (gpIL-5) cDNA was cloned by polymerase chain reaction (PCR) amplification of guinea pig spleen RNA and expressed as a secretion product from recombinant baculovirus-infected Sf9 insect cell cultures. The protein was purified to homogeneity by a four-step procedure that included immunoaffinity chromatography using polyclonal antipeptide antibodies against a region of the mature secreted cytokine. The cytokine was properly processed after the signal sequence by the Sf9 cells, was glycosylated with terminal mannose-containing oligosaccharide, and had proper disulfide-linked dimer structure as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The purified preparation was active in vitro and in vivo as determined by its ability to prime human basophils to release leukotriene C4 in the presence of C5a and to induce airway eosinophilia in naive guinea pigs.
为研究白细胞介素(IL)-5在改变哮喘气道功能中可能发挥的作用,我们制备了重组蛋白用于对豚鼠进行外源给药。通过聚合酶链反应(PCR)扩增豚鼠脾脏RNA克隆出豚鼠IL-5(gpIL-5)cDNA,并将其表达为重组杆状病毒感染的Sf9昆虫细胞培养物的分泌产物。该蛋白通过四步程序纯化至同质,这包括使用针对成熟分泌细胞因子区域的多克隆抗肽抗体进行免疫亲和层析。Sf9细胞在信号序列之后对该细胞因子进行了正确加工,其被末端含甘露糖的寡糖糖基化,并且通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳确定具有正确的二硫键连接的二聚体结构。通过其在C5a存在下引发人嗜碱性粒细胞释放白三烯C4以及在未致敏豚鼠中诱导气道嗜酸性粒细胞增多的能力,确定纯化制剂在体外和体内均具有活性。